Sort
51,593 grants matching “hepatitis”
Arsenic and immune response to influenza vaccination in pregnant women and newborns
$653,337Christopher D Heaney · Johns Hopkins University · R01 · FY2017 · ES
Non-esterified Fatty Acids and Cardiometabolic Disease in Older Adults
$653,228Luc Djousse · Brigham And Women'S Hospital · R01 · FY2019 · AG
Predicting Brain Changes in HIV/AIDS
$653,228Paul M Thompson · University Of California Los Angeles · R01 · FY2012 · NS
Mitochondrial DAMPs-driven Mechanisms of Liver Fibrosis in NASH
$653,226Yury Popov · Beth Israel Deaconess Medical Center · R01 · FY2024 · DK
Molecular Analysis of Alphavirus Membrane Fusion Protein
$653,224Margaret Kielian · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · AI
Molecular Analysis of Alphavirus Membrane Fusion Protein
$653,224Margaret Kielian · Albert Einstein College Of Medicine · R01 · FY2014 · AI
Molecular Analysis of Alphavirus Membrane Fusion Protein
$653,224Margaret Kielian · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · AI
Probing the specificity and activity of the metazoan Integrator complex
$653,188Karen L Adelman · Harvard Medical School · R01 · FY2020 · GM
Conserved Fetal Epigenomic and Metagenomic Signatures in a Primate Model of Maternal Obesity
$653,159Kjersti Marie Aagaard-Tillery · Baylor College Of Medicine · R01 · FY2019 · DK
Regulation and Role of Phosphatidate Phosphatase in Lipid Metabolism
$653,120George M. Carman · Rutgers, The State Univ Of N.J. · R35 · FY2024 · GM
Regulation and Role of Phosphatidate Phosphatase in Lipid Metabolism
$653,120George M. Carman · Rutgers, The State Univ Of N.J. · R35 · FY2023 · GM
Regulation and Role of Phosphatidate Phosphatase in Lipid Metabolism
$653,120George M. Carman · Rutgers, The State Univ Of N.J. · R35 · FY2022 · GM
Molecular signatures for liver cancer diagnosis and treatment stratification
$653,098Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Increasing Reach and Implementation of Evidence Based Programs for Cancer Control
$653,067Maria Eulalia Fernandez · University Of Texas Hlth Sci Ctr Houston · R01 · FY2016 · CA
Defining the therapeutic efficacy, tolerogenic potential, and genotoxicity of liver-targeted AAV gene therapy for hemophilia A
$652,874Graca Duarte Almeida-Porada · Wake Forest University Health Sciences · R01 · FY2025 · HL
A Needle Guidance System for Hepatic Tumor Ablation That Fuses Real-Time Ultrasou
$652,814Sharif Razzaque · Inneroptic Technology, Inc. · R44 · FY2012 · CA
Incidence of HIV Infection in a Cohort of IV Drug Users
$652,800Shruti H Mehta · Johns Hopkins University · R01 · FY2008 · DA
Regulation and Role of Phosphatidate Phosphatase in Lipid Metabolism
$652,774George M. Carman · Rutgers, The State Univ Of N.J. · R35 · FY2021 · GM
Bariatic Surgery: Outcomes & Impact on Pathophysiology
$652,763Paul David Berk · Columbia University Health Sciences · U01 · FY2007 · DK
Leveraging the plasma virome as a biological indicator of HIV risk and transmission networks among people who inject drugs
$652,755Abraham Kandathil · Johns Hopkins University · R01 · FY2024 · DA
International Center for Excellence in Research (ICER) in Uganda: Impact of ARVs
$652,752Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for HCV Trial
$652,668Jason S Haukoos · Denver Health And Hospital Authority · R01 · FY2018 · DA
Non Alcoholic Steatohepatitis Clinical Research Network
$652,507Srinivasan Dasarathy · Cleveland Clinic Lerner Com-Cwru · U01 · FY2020 · DK
Vitamin E Pharmacokinetics And Biomarkers In Normal And Obese Women
$652,454Mark A Levine · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Developing antiviral agents that inhibit HCV translation
$652,409Ptc Therapeutics, Inc. · R44 · FY2005 · AI